Collagen and Gelatin Market Size, Share, Trends and Forecast | Integra LifeSciences (US), DSM (Netherlands), Collplant Biotechnologies Ltd. (Israel), Nitta Gelatin Inc. (Japan)

Collagen and Gelatin Market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.6 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. Major factors driving the market growth at significant CAGR are increasing the prevalence of chronic diseases, increased number of orthopedic surgeries, and the launch of novel products in the market by key market players. Collagen-based products play a significant role in various surgical procedures and applications. Due to the biocompatibility and bioresorbable nature, collagen has gained popularity in the field of surgery.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

The collagen and gelatin industry is poised for significant growth in the near future. As consumer awareness of the health benefits associated with collagen and gelatin continues to rise, the demand for these products is expected to soar. Collagen, known for its contribution to healthy skin, hair, and joints, is increasingly sought after by the aging population and wellness-conscious individuals.

The bovine segment accounted for the largest share of the source segment in the collagen and gelatin market in 2022.

Based on Source, the collagen and gelatin market is segmented into bovine, porcine, and others. In 2022, the bovine source segment held the largest market share in the collagen and gelatin market. The large share of the segment is attributable to the growing adoption of bovine-derived collagen and gelatin in regenerative medicine. The increased usage of biomaterials is primarily due to the biocompatibility and biodegradability properties exhibited by these materials.

The orthopedic segment accounted for the largest share of the application segment in the collagen and gelatin market in 2022.

On the basis application, the global collagen market is segmented into orthopedic, wound care, dental, surgical cardiovascular, and other application. The global gelatin market is segmented into orthopedics, wound care, and others. The orthopedic segment accounted for the share of both the collagen and gelatin market in the year 2022. The demand for collagen is increasing because it is mainly used in orthopedic surgeries across the globe, and there is high demand for scaffolds and substitutes.

North America dominated the collagen and gelatin market.

Based on region, the collagen and gelatin market is segmented into North America, Europe, the Asia Pacific, Rest of the World. In 2022, North America dominated the market, followed by Europe. The increasing incidence of chronic diseases and the presence of top players operating in the are key factors supporting the growth of the North American collagen and gelatin market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Key Market Players:

The collagen and gelatin market is consolidated, with a small number of players competing for market shares. Integra LifeSciences (US), DSM (Netherlands), Collplant Biotechnologies Ltd. (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions Plc. (UK), Smith & Nephew Plc (UK) are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market

Recent Developments:

In January 2023, TELA Bio, Inc. launched NIVIS Fibrillar Collagen Pack. NIVIS Fibrillar Collagen Pack is an absorbent matrix of Type I and Type III bovine collagen proposed to manage moderately to heavily exudating wounds and to control minor bleeding.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=95663122&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.